Sofia, Bulgaria, July 18, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 17, 2025 the Company sold 72 486 (seventy two thousand four hundred eighty-six) repurchased own shares representing 0.04% of the share capital of the Company, at a total value of BGN 185 539.56 on the Bulgarian Stock Exchange, the average price per share was BGN 2.56.

Sofia, Bulgaria, July 17, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 16, 2025 the Company sold 1 000 (one thousand) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 2 580.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.58.

Sofia, Bulgaria, July 16, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 15, 2025 the Company sold 344 580 (three hundred forty-four thousand five hundred eighty) repurchased own shares representing 0.19% of the share capital of the Company, at a total value of BGN 898 228.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.61.

Sofia, Bulgaria, July 15, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 14, 2025 the Company sold 17 000 (seventeen thousand) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 45 250.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.66.

Sofia, Bulgaria, July 14, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 11, 2025 the Company sold 2 000 (two thousand) repurchased own shares representing 0.001% of the share capital of the Company, at a total value of BGN 5 160.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.58.

Sofia, Bulgaria, July 10, 2025 – In accordance with the requirements of Art.

Sofia, Bulgaria, July 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 2, 2025 the Company sold 518 619  (five  hundred eighteen thousand six hundred and eighteen) repurchased own shares representing 0.29% of the share capital of the Company, at a total value of BGN 3 640 994.86 on the Bulgarian Stock Exchange, the average price per share was BGN 7.02.

Sofia, Bulgaria, July 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 1, 2025 the Company sold 500 (five hundred) repurchased own shares representing 0.0003% of the share capital of the Company, at a total value of BGN 3 600.00 on the Bulgarian Stock Exchange, the average price per share was BGN 7.20.